Evaluation of Intravenous Lidocaine and Time to Regression of the Sensory Block After Spinal Anesthesia (ELSA Trial)

NCT04741880 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

66

Enrollment

OTHER_GOV

Sponsor class

Conditions

Anesthesia
Cancer

Interventions

DRUG: Lidocaine IV
DRUG: Saline

Sponsor

Instituto Nacional de Cancer, Brazil